Immunization of cattle using varying infective doses of Theileria parvalawrencei sporozoites derived from an African buffalo (Syncerus caffer and treatment with buparvaquone

Abstract

A Theileria parva lawrencei isolate in the form of a sporozoite stabilate, derived by feeding clean Rhipicephalus appendiculatus nymphal ticks on an African buffalo (Syncerus caffer) captured in the Laikipia District, Kenya, was inoculated into groups of cattle at dilutions between 100 and 10-3. Groups of 3 cattle infected with 1 ml inocula at 100, 10-1 and 10-2 dilutions were treated with 2·5 mg/kg body weight of buparvaquone on day 0 and similar groups were left untreated to act as controls. An additional group, given 100 dilution of the stabilate, was treated with buparvaquone on day 8 post-inoculation. It was found that all control cattle inoculated with the stabilate at dilutions between 100 and 10-2 became infected, but only 2 out of 3 cattle developed patent infections at 10-3 dilution. All 3 control cattle receiving 100 dilution died of theileriosis, 2 at 10-1 and 10-2 dilutions, and 1 at 10-3 dilution died.